Search

everythinglearnresearchcommunity

for

Search:↓

Nasopharyngeal carcinoma is a common cancer in Indonesia, with risk factors including genetics, diet, and Epstein-Barr virus, and is treated with advanced radiotherapy.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Blocking EGFR in mice causes hair loss and skin changes.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Hair follicle stem cells help maintain skin health by moving to and supporting the skin's surface layers.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Using special RNA to target a mutant gene fixed hair problems in mice.

Mutations in certain receptors can cause diseases and offer new treatment options.

Surgical removal of a scalp keratoacanthoma is effective and prevents recurrence, but hair may not regrow.

SVpgC2a cells show abnormal growth and keratin changes, modeling early cancer development.

Sorafenib can cause a unique skin reaction.

Nilotinib can cause keratosis pilaris, a skin condition.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Gefitinib therapy can cause unusual hair growth on the nose.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

Keratinocyte cytokines and genetic variations influence the development of moles and skin pigmentation.

Nilotinib can cause generalized keratosis pilaris.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Suppressing very long chain fatty acids is linked to skin cancer.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.

Overexpressing CtBP1 in skin cells causes skin and hair problems.

Keratoacanthoma changes as it grows, showing different hair follicle characteristics at each stage.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

A new rat strain with a specific gene mutation causes hair loss and kidney issues.